Successfully reported this slideshow.
Your SlideShare is downloading. ×

Session 2_ Introduction of NIP .pdf

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Loading in …3
×

Check these out next

1 of 28 Ad

More Related Content

Similar to Session 2_ Introduction of NIP .pdf (20)

Recently uploaded (20)

Advertisement

Session 2_ Introduction of NIP .pdf

  1. 1. vf]k lgz'Ns kfOG5 vf]k ;'/lIft x'G5 vf]kn] hLjg /Iff u5{ /fli6«o vf]k sfo{s|dsf] kl/ro ;];g @
  2. 2. 1/30/2023 2 Vff]kaf6 arfpg ;lsg] /f]ux? / hl6ntf ljkm/ pGd'ng gjlzz' wg':6+sf/ lgjf/0f kf]lnof] pGd'ng glhs
  3. 3. 1/30/2023 3 Vff]kaf6 arfpg ;lsg] /f]ux? / hl6ntf hfklgh OG;]kmnfOl6; bfb'/f
  4. 4. 1/30/2023 4 Vff]kaf6 arfpg ;lsg] /f]ux? / hl6ntf Eofu't] /f]u nx/] vf]sL l;=cf/=P;;
  5. 5. • kl/ro • vf]k sfo{qmdsf] d'Vo pknlAw / r'gf}tL • a[xt ax'aifL{o vf]k of]hgf (cMYP) ;g @)!&–@)@! sf nIo, p2]Zox? /fli6«o vf]k sfo{qmd
  6. 6. /fli6«o vf]k sfo{qmd (NIP) •g]kfn ;/sf/sf] k|fyldstf k|fKt sfo{qmd •hg :jf:Yosf] ;kmn dWo] k|d'v sfo{qmd •:jf:Yo If]qdf ;j} eGbf nfut k|efjsf/L (Cost effectiveness) •afn d[To'b/ 36fpg k|d'v e"ldsf /x]sf]
  7. 7. vf]k sfo{{qmdsf] kl/ro
  8. 8. @))@ : x]kf6fOl6; aL vf]k (Monovalent) @))$ : l8=lk=l6=–x]k aL vf]k (Tetravalent) @))* : h]=O{= vf]k -hf]lvdk"0f{ #! lhNnfx?_ @))( : x]df]lkmn; OGkmNo"P~hf aL -l8=lk=l6=,x]k aL, lxj_ (Pentavalent) @)!# : ?a]nf vf]k -bfb'/f–?a]nf vf]ksf] ?kdf_ @)!$ : topv switch, bopv / cfO{=lk=le= vf]k z'?jft @)!% : lk=l;=le= vf]k @)!% M bfb'/f ?j]nf bf];|f] dfqf z'?jft @)!^ : h]=O{= vf]k -;a} lhNnfx?df lj:tf/_ @)!^÷!& : Pr=lk=le= vf]k -sf:sL / lrtjg lhNnf_ @)!* : Pkm=cfO=kL=eL= vf]k -cfO{=lk=le= vf]k k|lt:yfkg_ @)@) M /f]6f efO{/;sf] vf]k eflj of]hgf (a[xt ax'aifL{o vf]k of]hgf): HPV, typhoid Decade of Vaccines gofF tyf k|of]udf /x]sf vf]kx?sf] lj:tf/
  9. 9. /fli6«o vf]k sfo{qmd (NIP) • nlIft ;d'x M !% dlxgf d'lgsf afnaflnsfx? • !@ j6f Antigen x? af6 M -d'Vo arfpg] /f]ux? Ifo/f]u, /f]6f, kf]lnof]dfOnfO{l6;, Go"df]lgof, d]lgGhfO{6L;, Eofu't]/f]u, nx/]vf]sL, x]kf6fO{6L; aL, wg'i6+sf/, bfb'/f, ?a]nf, / hfkflgh OG;]kmnfOl6;_ la?2sf vf]kx? lbO{G5 . • ue{jtL dlxnfx? M ue{jtL dlxnfx?sf nflu 6L=8L=-Td_ -wg'i6+sf/ / Eofu't] /f]u la?4_ gf]6 M vf]k ;]jf dfl;s b]ze/sf !^,))) eGbf w]/} vf]k s]Gb| / !&))) eGbf w]/} vf]k ;];gx? sf ;fy} lghL tyf u}/;/sf/L :jf:Yo ;+:yfx? Dffkm{t k|bfg ul/Fb} cfPsf] 5 .
  10. 10. vf]k ;]jf ;~rfng ;+:yfut vf]ks]Gb| (Fixed Session) : k|To]s dlxgf, k|To]s :jf:Yo ;+:yfdf afXo vf]k s]Gb| (Out Reach Sessions) : k|To]s dlxgf, ;fljssf uf=lj=;=x?sf] j8fx?df slDtdf # b]lv % j6f s]Gb|af6 3'DtL vf]k s]Gb| (Mobile clinics) : uf=kf=, g=kf=sf] :jf:Yo ;+:yfsf] ks8If]q leq /x]sf kx'Fraf6 6f9f ePsf jl:t, ;d'bfo / ef}uf]lns If]qdf slDtdf jif{sf] $ k6s vf]k s]Gb| :yfkgf u/L vf]k ;]jf k|bfg ul/Psf] Gff]6 M vf]k s]Gb|x?sf] of]hgf ubf{ t/fO{df cfwf b]lv ! 306f leq tyf kxf8 / lxdfnL If]qdf a9Ldf ! 306f #) ldg]6 leqsf] b'/Ldf vf]k s]Gb| :yfkgf ug'{kb{5 . xfnsf] gof+ ;+/rgf cg';f/ ;j} :yflgo txx?df vf]ksfo{qmdsf] ;'Idof]hgf tof/L Pj+ vf]k;];g k'gof]{hgf ug'{ kb{5 .
  11. 11. b'/b[li6 (Vision) g]kfndf vf]kaf6 arfpg ;lsg] /f]ux¿nfO{ z'Go cj:yfdf k'¥ofpg]] . Wo]o (Mission) /fli6«o vf]k sfo{qmd dfk{mt tf]lsPsf ;a} vf]kx¿ ;dtfd'ns ?kdf ;a} sf] kx'+rdf x'g] u/L k|To]s afnaflnsf / ue{jtL dlxnfnfO{ u'0f:tl/o, ;'/lIft / ;j{;'ne vf]k ;]jf lg/Gt/ ?kdf k|bfg ug{] . vf]k sfo{qmdsf] nIo (Goal) vf]kaf6 arfpg ;lsg] /f]uf0f' b/, ckfËtf / d[To'b/nfO{ sd ug'{ g} vf]k sfo{qmdsf] k|d'v nIo xf] . a[xt ax'aifL{o vf]k of]hgf (cMYP) ;g @)!&–@)@!
  12. 12. /fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf på]Zox? • vf]kaf6 arfpg ;lsg] /f]ux?sf] lgoGq0f, lgjf/0f / pGd'ngnfO{ ltj|tf lbO{ ;f] sf] lbuf]kg sfod /fVg] ✓kf]lnof] z'Go cj:yf sfod ug]{ -;g @)!)_ ✓gjlzz' wg'i6‹f/ lgjf/0f sfod /fVg] -;g @))%_ ✓bfb'/f lgjf/0f ug]{ -;g @)@#_ ✓x]kf6fO{6L; aL, h]=O{, afnaflnsfdf x'g] hl6n k|sf/sf] Ifo/f]u nufot cGo /f]ux? lgoGq0f u/L sfod /fVg] • k|To]s afnafnLsfn] k"0f{ vf]k nufPsf] ;'lglZrt ug]{ • ;a} vf]kx?sf] se/]h ;a} txdf (% k|ltzt eGbf dfyL k'¥ofO{ ;f] sfod /fVg]
  13. 13. /fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf på]Zox? •vf]k sf]N8r]g cfk"lt{ Aoj:yfkg ;'b[9 u/L u'0f:t/Lo vf]k ;]jfsf] ;'lglZrttf / kmf]x/d}nfsf] plrt Aoj:yfkg ug]{, •gofF tyf sd k|of]u ePsf vf]kx? ;dfj]z u/L vf]kaf6 hf]ufpg ;lsg] /f]ux?sf] lgoGq0fnfO{ cem} a9fjf lbg], •vf]kaf6 arfpg ;lsg] /f]ux?sf] vf]hk8tfn -;le{n]G;_ sfo{nfO{ lj:tf/ ug]{ .
  14. 14. • lakm/ /f]usf] pGd"ng • afn d[To'b/ df pNn]Vo sld -;x;|flAb nIf $ / % k|fKt_ • ;g @))% b]lv dft[ tyf gjlzz' wg'i6Íf/ /f]u lgjf/0f • ;g @)!) b]lv kf]lnof] /f]u z"Go cj:yf / pGd"ngsf] glhs • hfkflgh O{G;]kmnfO{l6; /f]u lgoGq0f • ;g @)!* b]lv ?a]nf tyf l;=cf/=P; (Congenital Rubella Syndrome) lgoGq0f • bfb'/f ?a]nf /f]u lgjf/0ftkm{ pGd"v • Affnaflnsfdf æx]kf6fO{l6; laÆ lgoGq0f -;g @)!(_ • vf]k4f/f arfpg ;lsg] cGo /f]ux¿df pNn]vgLo sdL • k"0f{ vf]k ;'lglZrttf 3f]if0ff • vf]k P]g / lgodfjnL hf/L vf]k sfo{qmdsf] d"Vo pknlAwx¿ ;g @)!* df Rubella and CRS lgoGq0f k|df0fLs/0f, WHO- SEARO af6 k|fKt
  15. 15. /fli6«o vf]k sfo{qmd / nIo -ax'jlif{o vf]k of]hgf / lbuf] ljsf; nIo_ k|fKt pknlJwx? sfod /fVb} -;Dj[l4sf] / lbuf] lasf; nIf k|flKtsf nflu_ • afn tyf dft[ d[To' b/df sld Nofpg] • cf}ift cfo'df jl[4 • /f]ux? pGd'ng ug]{ – kf]lnof] ;g @)@# • /f]ux? lgjf/0f ug]{ • dft[ tyf gjlzz' wg'i6+sf/sf] lgjf/0f -;g @))% b]lv _ sfod /fVg] • bfb'/f ?j]nf lgjf/0f -;g @)@# _ • /f]ux? lgoGq0f ug]{ • x]kf6fO{6L; aL, h]=O{, l6=jL cflb lgoGq0f / sfod ug]{ • k"0f{vf]k z'lglZrttf / lbuf]kgf -k"0f{vf]k o'Qm b]z 3f]if0ff ug]{_ nIo k|flKt, vf]k sfo{qmdsf] ljsf;, lj:tf/ / Joj:yfkgsf] nfuL ax'alif{o vf]k of]hgf @)!&-@!
  16. 16. /fli]6«o vf]k sfo{qmd cGtu{t ax'aifL{o vf]k of]hgf -@)!&–@!_ sf på]Zox? • u'0f:t/Lo vf]k ;]jfsf] nfuL cfk'tL{ Aoj:yf tyf vf]k sf]N8r]g Joj:yfkgsf] ;'99Ls/0f ug]{ • goFf tyf sd k|of]u ePsf vf]kx? ;dfj]z u/L vf]kaf6 hf]ufpg ;lsg] /f]ux?sf] lgoGq0fnfO{ cem} a9fjf lbg] • vf]kaf6 arfpg ;lsg] /f]ux?sf] vf]hk8tfn -;le{n]G;_ sfo{nfO{ lj:tf/ ug]{ • ! aif{ eGbf dflysf] pd]/ ;d'xsf] nfuL vf]k ;]jf lj:tf/ ub}{ n}hfg] • vf]k sfo{qmdsf] Aoj:yfkgdf gljgtd k|ljlw, cg';Gwfg / ;fdflhs kl/rfngdf a9fjf lbg] ;fy} lbuf] ljlQo Aoj:yfkg ;'lglZrt ug]{
  17. 17. lgoldt vf]k sfo{qmdsf r'gf}tLx? NDHS @)!^ @! Ü afnaflnsf k"0f{ vf]kaf6 al~rt 5g eg] ! Ü jRrf z'Go 8f]hdf 5g . 78% 21% 1% vf]k se/]hsf] cj:yf k"0f{ vf]k cf+lzs vf]k z'Go 8f]h
  18. 18. g]kfnsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf 92 82 82 88 85 80 79 81 66 91 86 84 88 86 81 81 84 73 86 78 77 85 81 78 78 80 70 0 10 20 30 40 50 60 70 80 90 100 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77
  19. 19. 90 82 82 86 85 83 79 82 69 87 83 81 85 83 80 84 81 75 82 74 74 80 76 75 77 79 71 0 10 20 30 40 50 60 70 80 90 100 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 k|b]z g+ ! sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  20. 20. 104 87 89 101 94 80 72 85 58 107 105 97 108 104 89 82 95 71 97 90 87 103 97 86 79 89 66 0 20 40 60 80 100 120 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 k|b]z g+ @ sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  21. 21. 84 73 73 75 75 72 75 74 57 81 72 71 73 72 72 69 73 60 82 68 68 72 71 69 69 70 61 0 10 20 30 40 50 60 70 80 90 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 afudtL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  22. 22. 73 72 72 75 74 71 83 71 70 72 74 74 76 75 74 80 74 77 66 69 69 71 70 70 78 70 75 0 10 20 30 40 50 60 70 80 90 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 u08sL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  23. 23. 98 87 87 91 90 85 90 86 79 98 90 87 94 91 87 89 88 84 92 81 81 89 85 84 86 85 80 0 20 40 60 80 100 120 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 k|b]z g+ % sf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  24. 24. 106 93 94 102 97 90 86 95 73 102 99 97 98 96 89 86 94 78 93 89 86 94 90 86 86 90 77 0 20 40 60 80 100 120 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 s0ff{nL k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  25. 25. 87 83 83 87 84 84 79 82 70 84 82 82 83 82 80 81 84 75 81 75 75 80 77 77 80 78 75 0 10 20 30 40 50 60 70 80 90 100 BCG DPT-Hepb-HiB 3rd OPV 3rd PCV 1st PCV 2nd PCV 3rd JE MR1 MR2 ChartTitle FY 2074/75 FY 2075/76 FY 2076/77 ;'b'/klZrd k|b]zsf] lgoldt vf]k sfo{qmdsf] ljut tLg aif{sf] se/]h cj:yf
  26. 26. lgoldt vf]k sfo{qmdsf d"Vo r'gf}lt / cj;/x? NDHS @)!^ @! Ü afnaflnsf k"0f{ vf]kaf6 al~rt 5g eg] ! Ü jRrf z'Go 8f]h != sl/j (( k|ltzt aRrfx?n] klxnf] vf]k z'? u/]tf klg pd]/ a9b} hf+bf kl5sf vf]kx?sf] dfqf lng 5'6 x'g] u/]sf] @= vf]k z'? u/]sf aRrfx? dWo sl/j @! k|ltzt afnaflnsfx? 8«kcfp6 eO{ &* k|ltzt dfq afnaflnsfx?n] k"0f{vf]k lnPsf] #= bfb'/f ?j]nfsf] bf];|f] dfqfsf] se/]h clt Go"g /x]sf] $= cem} ! k|ltzt Affnaflnsfx? s'g} klg vf]k gkfPsf] cj:yfdf /x]sf] -z'Go 8f]h_
  27. 27.  != /f]u lgoGq0f, lgjf/0f / pGd"ng ug{ vf]k ;]jf k|bfg ul/Psf] xf] .  @. cem}klg @@ k|ltzt aRrfx? k""0f{ vf]k kfpgaf6 alGrt 5g .  #= k|To]s dlxgf vf]k ;]jf k|bfg u/] kZrft vf]k k|fKt u/]sf / 5'6 ePsf aRRffsf] klxrfg ul/ vf]k lbnfpg' k5{ .  $. ;a} aRrfnfO{ k"0f{ vf]k lbnfpg' :jf:Yosld{sf] bfloTj xf] . ;f/f+z
  28. 28. wGojfb .

×